Posts by SPHPM APACMRDR

SPHPM APACMRDR

There is no information available yet.


APAC MRDR Registers 1500 Patients!

The APAC MRDR has now enrolled 1,500 patients! Thank you and congratulations to all the hardworking Study Coordinators and Principal…

Read More

Australia & New Zealand MRDR Registers 6,000 Patients

Congratulations to our sister registry, the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR) who have now…

Read More

HREC Approval for China sites

We are very excited to announce that two of our sites in China – Beijing Chaoyang Hospital and Renji Hospital,…

Read More

Rare Disease Day 2023

Tuesday 28 February is Rare Disease Day. Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity…

Read More

Monash University Christmas Holidays

Please note that Monash University and the APAC MRDR will be closed from 22 December 2022 to 2 January 2023,…

Read More

Welcome to our new Malaysian sites

In October the APAC MRDR welcomed three new sites from Malaysia. Ampang Hospital, Hospital Pulau Pinang (Penang General Hospital) and…

Read More

APAC MRDR Investigators’ Meeting – 2022 Recording

Missed the APAC MRDR Investigators’ Meeting for 2022? Watch the presentation below with talks from Professor Andrew Spencer, Dr Justin…

Read More

APAC MRDR Investigators’ Meeting 2022

We are pleased to invite you to our APAC MRDR Investigators’ Meeting at the 19th International Myeloma Society (IMS) Annual…

Read More

APAC MRDR Investigators’ Meeting 2021 – video

Missed the APAC MRDR Investigators’ Meeting in 2021? Watch the first presentation below where Professor Andrew Spencer provides an overview…

Read More

1000 Study Participants registered!

The APAC MRDR has reached a significant milestone with 1000 study participants registered from Korea, Singapore, Malaysia and Taiwan. A…

Read More